About Samuel Liang
Samuel Liang is a director at Thrombolex.
Experience
This experience comes from Samuel Liang's profile and from SEC filings. For roles taken from filings, the years are when the filings name Samuel Liang in the role, so the role may have started earlier or lasted longer.
AS
Austin Achieve Public Schools Current
School Board Member
2025 – Present
Thrombolex, Inc. Current
Director
2024 – Present · Kingston, NJ
Thrombolex makes blood clot treatment devices for healthcare professionals.
RC
Revival Healthcare Capital Current
Operating Partner
2021 – Present
HM
Health Plus Management Current
Board Member
2021 – Present
HC
Hanger Clinic
President, Hanger Clinic and Linkia; Executive Vice President, Hanger, Inc
2014 – 2020
BP
Bayer Pharmaceuticals
President/CEO, MEDRAD and Senior VP and Business Head, Radiology & Interventional, Bayer Healthcare
2010 – 2014
VT
Vascular Therapies
President/CEO
2008 – 2010
CO
Cordis
General Manager / Vice President Commercial Operations, Cordis
1984 – 2008
JJ
Johnson & Johnson
Vice President, J&J Stroke Management Group
1996 – 2005
Key Colleagues at Startups
The people Samuel Liang works with at each company, as listed on that company's latest Form D.
Thrombolex, Inc. · Form D, Mar 12, 2026
DB
David Bonita
Director
KH
Keegan Harper
Director
PS
Paul Stewart
Director
MW
Marvin Woodall
Executive officer and director
JC
CD
Clay DeMarcus
Director
MC
Michael Cerminaro
Executive officer and director